CAS ID: | 15687-27-1 |
Molecular Formula: | C13H18O2 |
Molecular Weight: | 206.3 g/mol |
Monoisotopic Mass: | 206.1307 g/mol |
Class: | Small Molecule |
Natural Product: | No |
Other Names: | CAP-PROFEN | APSIFEN-F | ADVIL MIGRAINE LIQUI-GELS | ADVIL LIQUI-GELS | ADVIL | SUSPREN | PROFLEX SR | PEDEA | MOTRIN MIGRAINE PAIN | MOTRIN IB | MOTRIN | MANORFEN | LOBUFEN | IBUSPRAY | IBUPRIN | DEEP RELIEF | CHILDREN'S MOTRIN | ANADIN ULTRA | ANADIN LIQUIFAST | ACHES-N-PAIN | NUROFEN MAX STRGTH MIG PAIN | FEMINAX EXPRESS | IBUPROFEN SODIUM | PROFEN | PHENSIC | NUROFEN CHILD | NUROFEN 400 | JUNIOR STRENGTH MOTRIN | IBUCALM | IBU-TAB | ARTHROFEN 600 | APSIFEN | NUROFEN MIGRAINE PAIN | U-18,573 | SECLODIN | RIMAFEN | PACIFENE | NUROFEN PLUS | MIGRAFEN | LIDIFEN | JUNIFEN | INOVEN | IBUPROHM | IBUMETIN | FEVERFEN | CO-OP | CHILDREN'S IBUPROFEN | BRUFEN RET | NUROFEN TENSION HEADACHE | NUROFEN ADVANCE | TAB-PROFEN | PHORPAIN | MIDOL | MAXA-GESIC | ISISFEN | IBUDERM | IBU-SLO | FLEXIMEX | CODAFEN CONTINUS | CHILDREN'S ELIXSURE | CALDOLOR | ANADIN JOINT PAIN | NEOPROFEN | IBUPROFEN LYSINE | RELCOFEN | PHORPAIN MAX STRGH | PAXOFEN | ORBIFEN | MEDIPREN | JUNIOR STRENGTH IBUPROFEN | IBUTIME | IBUPROFEN | IBUGEL FTE | IBUGEL | FENPAED | FENBID | CHILDREN'S ADVIL-FLAVORED | PROFLEX | PHOR PAIN | NUROFEN SOLB | NUPRIN | LIDIFEN-F | INABRIN | IBULEVE | CUPROFEN PLUS | ANADIN PERIOD PAIN RELIEF | IBULAR | IBUFAC | IBU-TAB 200 | FEMAFEN | EBUFAC | ARTHROFEN 400 | ARTHROFEN 200 | NUROFEN SINUS | NUROFEN FOR CHILD | NOVAPRIN | MANDAFEN | JUNIOR STRENGTH ADVIL | IBUMED | RUFEN | PEDIATRIC ADVIL | NUROFEN RECOVERY | NUROFEN BACK PAIN SR | MIDOL LIQUID GELS | IBUMOUSSE | FENBID FTE | CUPROFEN FOR CHILD | CHILDREN'S ADVIL |
Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
PubMed ID | 24974227 | Target ID | |
Uniprot ID | Name | ||
Model | vitro,mice | Fibrosis Disease | Cystic fibrosis |
Process I | |||
Process II | |||
Process III | |||
Mechanism |
Reference Record 2
PubMed ID | 25896805 | Target ID | |
Uniprot ID | Name | ||
Model | rat | Fibrosis Disease | Cardiac fibrosis |
Process I | |||
Process II | |||
Process III | prevenet collagen deposition | ||
Mechanism |
Trial Record 1
ClinicalTrial ID | NCT00219895 | Disease | Cystic fibrosis |
Phase | Not Applicable | Status | Completed |
First Received | September 22, 2005 | Last Verified | December 25, 2007 |
Sponsor | Ramsey, Bonnie, MD |
Trial Record 2
ClinicalTrial ID | NCT00531882 | Disease | Cystic fibrosis |
Phase | Not Applicable | Status | Completed |
First Received | September 19, 2007 | Last Verified | October 5, 2017 |
Sponsor | University Hospitals Cleveland Medical Center |